This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Multicenter phase 1/2a study using T-cell receptor...
Clinical trial

Multicenter phase 1/2a study using T-cell receptor gene therapy in metastatic melanoma

Read time: 1 mins
Last updated:2nd Apr 2012
To study the efficacy of this treatment strategy in inducing tumor-specific T cell immunity as measured by the presence of Mart-1 specific T cells in peripheral blood samples on several time points following adoptive transfer.
Category Value
Study start date 2012-04-02

View full details